

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 7.99083205 |
| 2 | * regulation of sequestering of triglyceride (GO:0010889) | 7.45596595 |
| 3 | brown fat cell differentiation (GO:0050873) | 5.82004113 |
| 4 | valine metabolic process (GO:0006573) | 5.64405450 |
| 5 | white fat cell differentiation (GO:0050872) | 5.25574016 |
| 6 | * regulation of cholesterol storage (GO:0010885) | 5.19934102 |
| 7 | fatty acid transmembrane transport (GO:1902001) | 5.15306476 |
| 8 | * triglyceride catabolic process (GO:0019433) | 4.72224954 |
| 9 | positive regulation of fatty acid oxidation (GO:0046321) | 4.58236919 |
| 10 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.51983553 |
| 11 | cGMP-mediated signaling (GO:0019934) | 4.45919242 |
| 12 | carnitine shuttle (GO:0006853) | 4.40495632 |
| 13 | fatty acid beta-oxidation (GO:0006635) | 4.37706148 |
| 14 | tricarboxylic acid cycle (GO:0006099) | 4.28674349 |
| 15 | lipid storage (GO:0019915) | 4.24920188 |
| 16 | lipid particle organization (GO:0034389) | 4.17969989 |
| 17 | * neutral lipid catabolic process (GO:0046461) | 4.15149614 |
| 18 | * acylglycerol catabolic process (GO:0046464) | 4.15149614 |
| 19 | biotin metabolic process (GO:0006768) | 4.14148750 |
| 20 | negative regulation of lipid storage (GO:0010888) | 4.10766055 |
| 21 | diacylglycerol metabolic process (GO:0046339) | 4.00315117 |
| 22 | * positive regulation of lipid storage (GO:0010884) | 3.98833412 |
| 23 | regulation of fatty acid oxidation (GO:0046320) | 3.98746398 |
| 24 | branched-chain amino acid metabolic process (GO:0009081) | 3.97582561 |
| 25 | branched-chain amino acid catabolic process (GO:0009083) | 3.96937825 |
| 26 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.94753727 |
| 27 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.84294037 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.83646865 |
| 29 | response to epinephrine (GO:0071871) | 3.82937978 |
| 30 | fatty acid oxidation (GO:0019395) | 3.79137950 |
| 31 | transcytosis (GO:0045056) | 3.78082940 |
| 32 | positive regulation of macrophage cytokine production (GO:0060907) | 3.77662850 |
| 33 | lipid oxidation (GO:0034440) | 3.74689254 |
| 34 | response to dietary excess (GO:0002021) | 3.70703016 |
| 35 | phagocytosis, recognition (GO:0006910) | 3.67284736 |
| 36 | polyol transport (GO:0015791) | 3.66011647 |
| 37 | fatty acid catabolic process (GO:0009062) | 3.62030768 |
| 38 | plasma lipoprotein particle clearance (GO:0034381) | 3.57575768 |
| 39 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.57326000 |
| 40 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.57248664 |
| 41 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.56264287 |
| 42 | NADH metabolic process (GO:0006734) | 3.53796170 |
| 43 | * regulation of lipid storage (GO:0010883) | 3.49482552 |
| 44 | positive regulation of sterol transport (GO:0032373) | 3.49469193 |
| 45 | positive regulation of cholesterol transport (GO:0032376) | 3.49469193 |
| 46 | carnitine transmembrane transport (GO:1902603) | 3.48119057 |
| 47 | regulation of gonadotropin secretion (GO:0032276) | 3.47155019 |
| 48 | barbed-end actin filament capping (GO:0051016) | 3.45510413 |
| 49 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.45292385 |
| 50 | tricarboxylic acid metabolic process (GO:0072350) | 3.44712431 |
| 51 | positive regulation of glomerulus development (GO:0090193) | 3.42626370 |
| 52 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.42449231 |
| 53 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.40297213 |
| 54 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.38609812 |
| 55 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.38609812 |
| 56 | modulation by symbiont of host immune response (GO:0052553) | 3.38609812 |
| 57 | positive regulation by symbiont of host defense response (GO:0052509) | 3.38609812 |
| 58 | modulation by symbiont of host defense response (GO:0052031) | 3.38609812 |
| 59 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.38609812 |
| 60 | lipoprotein transport (GO:0042953) | 3.36247417 |
| 61 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.35163874 |
| 62 | intracellular lipid transport (GO:0032365) | 3.29683057 |
| 63 | * regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.27998395 |
| 64 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.26475440 |
| 65 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.26349558 |
| 66 | regulation of cofactor metabolic process (GO:0051193) | 3.25741753 |
| 67 | regulation of coenzyme metabolic process (GO:0051196) | 3.25741753 |
| 68 | amino-acid betaine transport (GO:0015838) | 3.24667325 |
| 69 | carnitine transport (GO:0015879) | 3.24667325 |
| 70 | cellular response to zinc ion (GO:0071294) | 3.24586743 |
| 71 | detection of calcium ion (GO:0005513) | 3.24551853 |
| 72 | apoptotic cell clearance (GO:0043277) | 3.24513928 |
| 73 | phospholipid homeostasis (GO:0055091) | 3.24161242 |
| 74 | * triglyceride metabolic process (GO:0006641) | 3.21728895 |
| 75 | protein heterotrimerization (GO:0070208) | 3.20388358 |
| 76 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.19663649 |
| 77 | negative regulation of granulocyte differentiation (GO:0030853) | 3.19553750 |
| 78 | cellular response to lithium ion (GO:0071285) | 3.15402703 |
| 79 | 2-oxoglutarate metabolic process (GO:0006103) | 3.12637821 |
| 80 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.10786833 |
| 81 | ethanol oxidation (GO:0006069) | 3.10682798 |
| 82 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.09084823 |
| 83 | positive regulation of lipid catabolic process (GO:0050996) | 3.09016616 |
| 84 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.08289362 |
| 85 | negative regulation of macrophage differentiation (GO:0045650) | 3.05468065 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.04203105 |
| 87 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.04203105 |
| 88 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.03910368 |
| 89 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.00846503 |
| 90 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.99721155 |
| 91 | response to lipoprotein particle (GO:0055094) | 2.99388393 |
| 92 | negative regulation of protein autophosphorylation (GO:0031953) | 2.99081953 |
| 93 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.99033378 |
| 94 | * acylglycerol metabolic process (GO:0006639) | 2.98204433 |
| 95 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.98163489 |
| 96 | ovulation from ovarian follicle (GO:0001542) | 2.97802935 |
| 97 | * glycerolipid catabolic process (GO:0046503) | 2.95280775 |
| 98 | phosphatidic acid metabolic process (GO:0046473) | 2.94618811 |
| 99 | phosphatidic acid biosynthetic process (GO:0006654) | 2.94618811 |
| 100 | * neutral lipid metabolic process (GO:0006638) | 2.93235015 |
| 101 | negative regulation of norepinephrine secretion (GO:0010700) | 2.93234073 |
| 102 | activation of protein kinase A activity (GO:0034199) | 2.93005656 |
| 103 | cardiac muscle contraction (GO:0060048) | 2.92930551 |
| 104 | long-chain fatty acid transport (GO:0015909) | 2.92921545 |
| 105 | negative regulation of amino acid transport (GO:0051956) | 2.90924861 |
| 106 | response to phenylpropanoid (GO:0080184) | 2.85234734 |
| 107 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.84231925 |
| 108 | cellular response to epinephrine stimulus (GO:0071872) | 2.83441095 |
| 109 | * triglyceride biosynthetic process (GO:0019432) | 2.82654886 |
| 110 | endothelium development (GO:0003158) | 2.82610328 |
| 111 | cAMP biosynthetic process (GO:0006171) | 2.80551666 |
| 112 | oxaloacetate metabolic process (GO:0006107) | 2.78792047 |
| 113 | acetyl-CoA metabolic process (GO:0006084) | 2.74637339 |
| 114 | growth hormone receptor signaling pathway (GO:0060396) | 2.74240370 |
| 115 | acyl-CoA biosynthetic process (GO:0071616) | 2.73386908 |
| 116 | thioester biosynthetic process (GO:0035384) | 2.73386908 |
| 117 | cardiac myofibril assembly (GO:0055003) | 2.73327404 |
| 118 | acyl-CoA metabolic process (GO:0006637) | 2.72425839 |
| 119 | thioester metabolic process (GO:0035383) | 2.72425839 |
| 120 | creatine metabolic process (GO:0006600) | 2.71861035 |
| 121 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.71554014 |
| 122 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.71504636 |
| 123 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.71500004 |
| 124 | succinate metabolic process (GO:0006105) | 2.70604405 |
| 125 | regulation of receptor binding (GO:1900120) | 2.70413149 |
| 126 | monocarboxylic acid catabolic process (GO:0072329) | 2.70277320 |
| 127 | regulation of macrophage cytokine production (GO:0010935) | 2.70035687 |
| 128 | positive regulation of p38MAPK cascade (GO:1900745) | 2.69171548 |
| 129 | cellular response to vitamin (GO:0071295) | 2.68518124 |
| 130 | * neutral lipid biosynthetic process (GO:0046460) | 2.68137219 |
| 131 | * acylglycerol biosynthetic process (GO:0046463) | 2.68137219 |
| 132 | negative regulation of phagocytosis (GO:0050765) | 2.67034901 |
| 133 | cellular response to monoamine stimulus (GO:0071868) | 2.66485616 |
| 134 | cellular response to catecholamine stimulus (GO:0071870) | 2.66485616 |
| 135 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.66402880 |
| 136 | plasma membrane repair (GO:0001778) | 2.66322223 |
| 137 | sarcomere organization (GO:0045214) | 2.66250065 |
| 138 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.65272037 |
| 139 | cell migration involved in heart development (GO:0060973) | 2.65205559 |
| 140 | fatty acid homeostasis (GO:0055089) | 2.65051440 |
| 141 | alpha-linolenic acid metabolic process (GO:0036109) | 2.64309109 |
| 142 | regulation of cell communication by electrical coupling (GO:0010649) | 2.63541487 |
| 143 | keratan sulfate catabolic process (GO:0042340) | 2.62932004 |
| 144 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.61686858 |
| 145 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.61154982 |
| 146 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.60856443 |
| 147 | regulation of triglyceride catabolic process (GO:0010896) | 2.60839731 |
| 148 | positive regulation of interferon-alpha production (GO:0032727) | 2.60595859 |
| 149 | positive regulation of cholesterol efflux (GO:0010875) | 2.60359271 |
| 150 | pentose-phosphate shunt (GO:0006098) | 2.59312778 |
| 151 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.58664956 |
| 152 | NADPH regeneration (GO:0006740) | 2.58510739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.48565934 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.84329152 |
| 3 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.34344114 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.17933143 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.93415679 |
| 6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.75056483 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.41986127 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.37232010 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29183402 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23611404 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.18800307 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.16456911 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.15768320 |
| 14 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.12650267 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.11953713 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.04904182 |
| 17 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 10.9290051 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.91098594 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90216254 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84742362 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.84632922 |
| 22 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.83412763 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82936974 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82650822 |
| 25 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.81889632 |
| 26 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.81889632 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80615165 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78862749 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.75710661 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74401875 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73045956 |
| 32 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.72611344 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72428332 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.64479784 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.64124252 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.58838580 |
| 37 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.58512589 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54404074 |
| 39 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.53991993 |
| 40 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.52428543 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.51718273 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48307449 |
| 43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.47732869 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.45778359 |
| 45 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.44439114 |
| 46 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.44439114 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44100114 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44037803 |
| 49 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.38546972 |
| 50 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.37743077 |
| 51 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.35530630 |
| 52 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.33823907 |
| 53 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.32914685 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32583931 |
| 55 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32242140 |
| 56 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.31926787 |
| 57 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.31926787 |
| 58 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.31079446 |
| 59 | CJUN_26792858_Chip-Seq_BT549_Human | 1.29821963 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28140915 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25708011 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24476713 |
| 63 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.23812577 |
| 64 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21217210 |
| 65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20344085 |
| 66 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19974796 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17532635 |
| 68 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.07324282 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07202388 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06639837 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06011220 |
| 72 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04498179 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04102118 |
| 74 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.02940756 |
| 75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01690363 |
| 76 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00313273 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98856340 |
| 78 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98559873 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98104853 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96984320 |
| 81 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94411962 |
| 82 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93609514 |
| 83 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.93395781 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92691903 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91171388 |
| 86 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90925294 |
| 87 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.90309277 |
| 88 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.90008369 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89193141 |
| 90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88819942 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88609917 |
| 92 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.88245714 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88026962 |
| 94 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87921943 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87808765 |
| 96 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87606525 |
| 97 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87410503 |
| 98 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.86990000 |
| 99 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86896136 |
| 100 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86794831 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86780872 |
| 102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85301478 |
| 103 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.85209866 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85052295 |
| 105 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84979930 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84417777 |
| 107 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83138691 |
| 108 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82757772 |
| 109 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82385913 |
| 110 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.81645364 |
| 111 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.81609159 |
| 112 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.80756663 |
| 113 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.80227440 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.80197986 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80020793 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79605572 |
| 117 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79534154 |
| 118 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79471785 |
| 119 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.79416972 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79151902 |
| 121 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79066659 |
| 122 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.78267364 |
| 123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77299926 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77211595 |
| 125 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77150133 |
| 126 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77070327 |
| 127 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.76868871 |
| 128 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74556780 |
| 129 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.74545668 |
| 130 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.74053060 |
| 131 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.73331509 |
| 132 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72317715 |
| 133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.70946725 |
| 134 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70259816 |
| 135 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.69391262 |
| 136 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.69302266 |
| 137 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.68069017 |
| 138 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.67332080 |
| 139 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.67130258 |
| 140 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66795174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 5.57385688 |
| 2 | * MP0004130_abnormal_muscle_cell | 4.47170371 |
| 3 | MP0004185_abnormal_adipocyte_glucose | 4.14823355 |
| 4 | MP0005666_abnormal_adipose_tissue | 4.11175654 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 4.03360449 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 3.68454403 |
| 7 | MP0003646_muscle_fatigue | 3.11322488 |
| 8 | * MP0005375_adipose_tissue_phenotype | 2.75949862 |
| 9 | MP0002971_abnormal_brown_adipose | 2.40544796 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.37799082 |
| 11 | MP0000751_myopathy | 2.35562203 |
| 12 | MP0003828_pulmonary_edema | 2.21913958 |
| 13 | MP0000013_abnormal_adipose_tissue | 2.21786819 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.16345769 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.11259862 |
| 16 | MP0003724_increased_susceptibility_to | 2.06156380 |
| 17 | MP0005275_abnormal_skin_tensile | 2.02493181 |
| 18 | MP0009115_abnormal_fat_cell | 1.97261615 |
| 19 | MP0004215_abnormal_myocardial_fiber | 1.90973277 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.86791866 |
| 21 | MP0003011_delayed_dark_adaptation | 1.86735879 |
| 22 | MP0000343_altered_response_to | 1.85277713 |
| 23 | MP0005330_cardiomyopathy | 1.82322656 |
| 24 | MP0003221_abnormal_cardiomyocyte_apopto | 1.70320385 |
| 25 | MP0000750_abnormal_muscle_regeneration | 1.69007662 |
| 26 | * MP0005334_abnormal_fat_pad | 1.67500148 |
| 27 | MP0004087_abnormal_muscle_fiber | 1.66729355 |
| 28 | * MP0001544_abnormal_cardiovascular_syste | 1.63994127 |
| 29 | * MP0005385_cardiovascular_system_phenoty | 1.63994127 |
| 30 | MP0004036_abnormal_muscle_relaxation | 1.60642375 |
| 31 | MP0003690_abnormal_glial_cell | 1.58402140 |
| 32 | * MP0002972_abnormal_cardiac_muscle | 1.57635294 |
| 33 | * MP0010329_abnormal_lipoprotein_level | 1.52833341 |
| 34 | * MP0000003_abnormal_adipose_tissue | 1.52531754 |
| 35 | MP0006138_congestive_heart_failure | 1.52490072 |
| 36 | * MP0008775_abnormal_heart_ventricle | 1.52310018 |
| 37 | MP0003137_abnormal_impulse_conducting | 1.49124055 |
| 38 | MP0005535_abnormal_body_temperature | 1.46854791 |
| 39 | MP0000749_muscle_degeneration | 1.44491834 |
| 40 | MP0001661_extended_life_span | 1.43678029 |
| 41 | MP0002970_abnormal_white_adipose | 1.41827887 |
| 42 | MP0003186_abnormal_redox_activity | 1.37689547 |
| 43 | * MP0005620_abnormal_muscle_contractility | 1.36280328 |
| 44 | * MP0002118_abnormal_lipid_homeostasis | 1.35865045 |
| 45 | MP0003436_decreased_susceptibility_to | 1.35018186 |
| 46 | MP0003303_peritoneal_inflammation | 1.34009488 |
| 47 | MP0005595_abnormal_vascular_smooth | 1.33585286 |
| 48 | MP0003329_amyloid_beta_deposits | 1.31472064 |
| 49 | MP0004272_abnormal_basement_membrane | 1.30143872 |
| 50 | MP0004510_myositis | 1.29860552 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.29609314 |
| 52 | MP0004484_altered_response_of | 1.29246878 |
| 53 | MP0010630_abnormal_cardiac_muscle | 1.27972657 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.27578600 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.22786932 |
| 56 | MP0003959_abnormal_lean_body | 1.21830107 |
| 57 | MP0006082_CNS_inflammation | 1.21656539 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.19313478 |
| 59 | MP0005647_abnormal_sex_gland | 1.14362607 |
| 60 | MP0002106_abnormal_muscle_physiology | 1.13240673 |
| 61 | MP0000747_muscle_weakness | 1.12981198 |
| 62 | MP0002295_abnormal_pulmonary_circulatio | 1.10809404 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.09557672 |
| 64 | MP0010368_abnormal_lymphatic_system | 1.09477207 |
| 65 | MP0003448_altered_tumor_morphology | 1.06520732 |
| 66 | MP0002419_abnormal_innate_immunity | 1.06264231 |
| 67 | * MP0002078_abnormal_glucose_homeostasis | 1.05941286 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.05732441 |
| 69 | MP0005448_abnormal_energy_balance | 1.05156699 |
| 70 | MP0005503_abnormal_tendon_morphology | 1.04167629 |
| 71 | MP0001835_abnormal_antigen_presentation | 1.03978629 |
| 72 | * MP0000759_abnormal_skeletal_muscle | 1.03292502 |
| 73 | MP0002876_abnormal_thyroid_physiology | 0.99801244 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.99173008 |
| 75 | MP0000609_abnormal_liver_physiology | 0.98705327 |
| 76 | MP0009785_altered_susceptibility_to | 0.95526625 |
| 77 | MP0001727_abnormal_embryo_implantation | 0.94450390 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 0.93886172 |
| 79 | MP0001545_abnormal_hematopoietic_system | 0.93886172 |
| 80 | MP0000767_abnormal_smooth_muscle | 0.93320979 |
| 81 | MP0001958_emphysema | 0.92543154 |
| 82 | MP0002909_abnormal_adrenal_gland | 0.92468928 |
| 83 | MP0009278_abnormal_bone_marrow | 0.92468313 |
| 84 | MP0003279_aneurysm | 0.91979123 |
| 85 | MP0001881_abnormal_mammary_gland | 0.91467635 |
| 86 | MP0002108_abnormal_muscle_morphology | 0.91093824 |
| 87 | * MP0000249_abnormal_blood_vessel | 0.90124041 |
| 88 | MP0005369_muscle_phenotype | 0.89822689 |
| 89 | MP0005164_abnormal_response_to | 0.87715149 |
| 90 | MP0002127_abnormal_cardiovascular_syste | 0.85920432 |
| 91 | MP0003045_fibrosis | 0.85164991 |
| 92 | MP0003868_abnormal_feces_composition | 0.84561787 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.82903097 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.82815314 |
| 95 | MP0004085_abnormal_heartbeat | 0.81496267 |
| 96 | MP0002933_joint_inflammation | 0.81218126 |
| 97 | MP0002166_altered_tumor_susceptibility | 0.81204270 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.80566571 |
| 99 | MP0005452_abnormal_adipose_tissue | 0.80468533 |
| 100 | MP0002269_muscular_atrophy | 0.78770489 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 0.78493439 |
| 102 | MP0002139_abnormal_hepatobiliary_system | 0.78462063 |
| 103 | MP0002006_tumorigenesis | 0.77050660 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.76701039 |
| 105 | MP0009840_abnormal_foam_cell | 0.75797141 |
| 106 | MP0009643_abnormal_urine_homeostasis | 0.75322900 |
| 107 | MP0003195_calcinosis | 0.75262727 |
| 108 | MP0001853_heart_inflammation | 0.74981859 |
| 109 | MP0001756_abnormal_urination | 0.74947344 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.74819535 |
| 111 | MP0005000_abnormal_immune_tolerance | 0.74336659 |
| 112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74153219 |
| 113 | MP0002090_abnormal_vision | 0.73427981 |
| 114 | MP0003091_abnormal_cell_migration | 0.72683793 |
| 115 | MP0003075_altered_response_to | 0.71708110 |
| 116 | MP0005025_abnormal_response_to | 0.70820212 |
| 117 | MP0005076_abnormal_cell_differentiation | 0.70238681 |
| 118 | MP0003300_gastrointestinal_ulcer | 0.69886884 |
| 119 | MP0000604_amyloidosis | 0.69468950 |
| 120 | MP0008469_abnormal_protein_level | 0.69340394 |
| 121 | MP0005165_increased_susceptibility_to | 0.68587213 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.68464456 |
| 123 | MP0005365_abnormal_bile_salt | 0.68094294 |
| 124 | MP0002148_abnormal_hypersensitivity_rea | 0.68018569 |
| 125 | MP0002060_abnormal_skin_morphology | 0.67441989 |
| 126 | MP0002896_abnormal_bone_mineralization | 0.64836968 |
| 127 | * MP0003948_abnormal_gas_homeostasis | 0.62257977 |
| 128 | MP0001984_abnormal_olfaction | 0.61658678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 4.90059838 |
| 2 | Myoglobinuria (HP:0002913) | 4.36748348 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 3.99420764 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.99420764 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.99420764 |
| 6 | Acanthosis nigricans (HP:0000956) | 3.82154483 |
| 7 | Increased connective tissue (HP:0009025) | 3.81877974 |
| 8 | Hypertriglyceridemia (HP:0002155) | 3.74541484 |
| 9 | Sudden death (HP:0001699) | 3.68465598 |
| 10 | Hypoglycemic coma (HP:0001325) | 3.59294814 |
| 11 | Lipoatrophy (HP:0100578) | 3.58679821 |
| 12 | Muscle fiber splitting (HP:0003555) | 3.53969446 |
| 13 | Difficulty running (HP:0009046) | 3.51907956 |
| 14 | Ketoacidosis (HP:0001993) | 3.51415512 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 3.50080204 |
| 16 | Ventricular tachycardia (HP:0004756) | 3.41486374 |
| 17 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.40538810 |
| 18 | Hyperglycinuria (HP:0003108) | 3.39499060 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.35724024 |
| 20 | Rhabdomyolysis (HP:0003201) | 3.33458611 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33088092 |
| 22 | Atrioventricular block (HP:0001678) | 3.31030850 |
| 23 | Bone cyst (HP:0012062) | 3.21193534 |
| 24 | Axonal loss (HP:0003447) | 3.19288156 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.16676749 |
| 26 | Abnormal atrioventricular conduction (HP:0005150) | 3.03152347 |
| 27 | Heart block (HP:0012722) | 3.03035002 |
| 28 | Hyporeflexia of lower limbs (HP:0002600) | 2.99576532 |
| 29 | Exercise-induced myalgia (HP:0003738) | 2.92334008 |
| 30 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.89962002 |
| 31 | Right ventricular cardiomyopathy (HP:0011663) | 2.89736752 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 2.88604091 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 2.87113295 |
| 34 | Atrial fibrillation (HP:0005110) | 2.86940309 |
| 35 | Ketosis (HP:0001946) | 2.86821056 |
| 36 | Increased muscle lipid content (HP:0009058) | 2.82810687 |
| 37 | Type 1 muscle fiber predominance (HP:0003803) | 2.80215920 |
| 38 | Calf muscle hypertrophy (HP:0008981) | 2.79969857 |
| 39 | Increased serum pyruvate (HP:0003542) | 2.79677992 |
| 40 | Neck muscle weakness (HP:0000467) | 2.79601377 |
| 41 | Ankle contracture (HP:0006466) | 2.79288109 |
| 42 | Frequent falls (HP:0002359) | 2.79028007 |
| 43 | Distal lower limb muscle weakness (HP:0009053) | 2.77942346 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.77231776 |
| 45 | Esophageal varix (HP:0002040) | 2.76276423 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 2.75460360 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.75460360 |
| 48 | Palpitations (HP:0001962) | 2.72548530 |
| 49 | Complement deficiency (HP:0004431) | 2.71876902 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.69244077 |
| 51 | Increased variability in muscle fiber diameter (HP:0003557) | 2.67963604 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.67028418 |
| 53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.65497050 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.65254742 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.65254742 |
| 56 | Abnormality of the periventricular white matter (HP:0002518) | 2.63045374 |
| 57 | Primary atrial arrhythmia (HP:0001692) | 2.60984883 |
| 58 | Neoplasm of head and neck (HP:0012288) | 2.59373399 |
| 59 | Esophageal neoplasm (HP:0100751) | 2.59373399 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.54461933 |
| 61 | Dilated cardiomyopathy (HP:0001644) | 2.53139599 |
| 62 | Generalized aminoaciduria (HP:0002909) | 2.50410783 |
| 63 | Conjunctival hamartoma (HP:0100780) | 2.50095483 |
| 64 | Polycythemia (HP:0001901) | 2.49574873 |
| 65 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.46526161 |
| 66 | Supraventricular arrhythmia (HP:0005115) | 2.46478170 |
| 67 | Protrusio acetabuli (HP:0003179) | 2.45877002 |
| 68 | Supraventricular tachycardia (HP:0004755) | 2.43395098 |
| 69 | Abnormality of glycolysis (HP:0004366) | 2.43071796 |
| 70 | Cerebral aneurysm (HP:0004944) | 2.40469166 |
| 71 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.40048597 |
| 72 | * Nausea (HP:0002018) | 2.39992026 |
| 73 | Facial diplegia (HP:0001349) | 2.39390751 |
| 74 | Vertebral compression fractures (HP:0002953) | 2.39343219 |
| 75 | Hydroxyprolinuria (HP:0003080) | 2.39035318 |
| 76 | Abnormality of proline metabolism (HP:0010907) | 2.39035318 |
| 77 | Abnormality of the foot musculature (HP:0001436) | 2.37401672 |
| 78 | Nuclear cataract (HP:0100018) | 2.36078400 |
| 79 | Tetraparesis (HP:0002273) | 2.35284890 |
| 80 | Toxemia of pregnancy (HP:0100603) | 2.34593460 |
| 81 | Neurofibrillary tangles (HP:0002185) | 2.34045052 |
| 82 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.33106169 |
| 83 | Abnormality of macrophages (HP:0004311) | 2.30587240 |
| 84 | Foot dorsiflexor weakness (HP:0009027) | 2.30020211 |
| 85 | Spinal rigidity (HP:0003306) | 2.28608499 |
| 86 | Mutism (HP:0002300) | 2.27756859 |
| 87 | Multiple enchondromatosis (HP:0005701) | 2.26830450 |
| 88 | Ragged-red muscle fibers (HP:0003200) | 2.25967745 |
| 89 | Hypercortisolism (HP:0001578) | 2.25526546 |
| 90 | * Myocardial infarction (HP:0001658) | 2.25350322 |
| 91 | Hepatic necrosis (HP:0002605) | 2.25131781 |
| 92 | Abnormal eating behavior (HP:0100738) | 2.24653431 |
| 93 | Pulmonary artery stenosis (HP:0004415) | 2.23782572 |
| 94 | Bundle branch block (HP:0011710) | 2.22999516 |
| 95 | Insulin resistance (HP:0000855) | 2.22589389 |
| 96 | Broad metatarsal (HP:0001783) | 2.22406734 |
| 97 | Cerebral inclusion bodies (HP:0100314) | 2.21986192 |
| 98 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.21611319 |
| 99 | Subaortic stenosis (HP:0001682) | 2.21611319 |
| 100 | Disinhibition (HP:0000734) | 2.20320574 |
| 101 | Autoimmune thrombocytopenia (HP:0001973) | 2.20094662 |
| 102 | Action tremor (HP:0002345) | 2.18989300 |
| 103 | Amyloidosis (HP:0011034) | 2.17831195 |
| 104 | Abnormality of the calf musculature (HP:0001430) | 2.16829860 |
| 105 | Hyperglycemia (HP:0003074) | 2.16559953 |
| 106 | Dysostosis multiplex (HP:0000943) | 2.16293132 |
| 107 | Neoplasm of the adrenal gland (HP:0100631) | 2.15883772 |
| 108 | Rimmed vacuoles (HP:0003805) | 2.13842684 |
| 109 | Abnormality of complement system (HP:0005339) | 2.12119969 |
| 110 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.12013800 |
| 111 | EMG: myopathic abnormalities (HP:0003458) | 2.11055776 |
| 112 | Back pain (HP:0003418) | 2.10938787 |
| 113 | Hyperammonemia (HP:0001987) | 2.10160477 |
| 114 | Syncope (HP:0001279) | 2.08815043 |
| 115 | Scapular winging (HP:0003691) | 2.08727922 |
| 116 | Decreased subcutaneous fat (HP:0001002) | 2.08335357 |
| 117 | Steppage gait (HP:0003376) | 2.07888897 |
| 118 | Bulbar palsy (HP:0001283) | 2.07556149 |
| 119 | Polyphagia (HP:0002591) | 2.07002726 |
| 120 | Follicular hyperkeratosis (HP:0007502) | 2.06364441 |
| 121 | Growth hormone excess (HP:0000845) | 2.05534090 |
| 122 | Recurrent bacterial skin infections (HP:0005406) | 2.03257371 |
| 123 | Hemorrhage of the eye (HP:0011885) | 2.02347017 |
| 124 | Muscle stiffness (HP:0003552) | 2.01438067 |
| 125 | Gowers sign (HP:0003391) | 2.00781644 |
| 126 | Abnormality of alanine metabolism (HP:0010916) | 1.98814532 |
| 127 | Pigmentary retinal degeneration (HP:0001146) | 1.98285758 |
| 128 | Slender build (HP:0001533) | 1.97071086 |
| 129 | Vascular tortuosity (HP:0004948) | 1.97020155 |
| 130 | Myotonia (HP:0002486) | 1.94687990 |
| 131 | Testicular atrophy (HP:0000029) | 1.93410984 |
| 132 | Prolonged QT interval (HP:0001657) | 1.90918153 |
| 133 | Hematochezia (HP:0002573) | 1.90650363 |
| 134 | Ventricular arrhythmia (HP:0004308) | 1.88194869 |
| 135 | Subcapsular cataract (HP:0000523) | 1.87628613 |
| 136 | Gingivitis (HP:0000230) | 1.87179927 |
| 137 | Mucopolysacchariduria (HP:0008155) | 1.86863658 |
| 138 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86863658 |
| 139 | Hyperalaninemia (HP:0003348) | 1.85898523 |
| 140 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85898523 |
| 141 | Distal lower limb amyotrophy (HP:0008944) | 1.85745884 |
| 142 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84216770 |
| 143 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84216770 |
| 144 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84216770 |
| 145 | Aortic aneurysm (HP:0004942) | 1.82381338 |
| 146 | * Skin nodule (HP:0200036) | 1.82007360 |
| 147 | Arterial tortuosity (HP:0005116) | 1.80017578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.59292340 |
| 2 | CAMK1D | 3.69984985 |
| 3 | TTN | 3.35883515 |
| 4 | BCKDK | 3.31742580 |
| 5 | PDK4 | 2.91737433 |
| 6 | PDK3 | 2.91737433 |
| 7 | ERN1 | 2.58308517 |
| 8 | CAMK1G | 2.55824985 |
| 9 | PKN2 | 2.52689251 |
| 10 | LMTK2 | 2.37370857 |
| 11 | SIK1 | 2.37363297 |
| 12 | RIPK1 | 2.19891765 |
| 13 | PDK2 | 2.03994778 |
| 14 | DDR2 | 2.01446239 |
| 15 | NEK9 | 1.79047241 |
| 16 | RIPK4 | 1.78553770 |
| 17 | CAMK1 | 1.71214723 |
| 18 | PHKG2 | 1.70677966 |
| 19 | PHKG1 | 1.70677966 |
| 20 | MOS | 1.67571580 |
| 21 | TESK1 | 1.65953374 |
| 22 | IRAK3 | 1.63088784 |
| 23 | LATS2 | 1.61344249 |
| 24 | MAPK4 | 1.60381035 |
| 25 | PBK | 1.57073261 |
| 26 | TGFBR2 | 1.56715745 |
| 27 | INSRR | 1.53213651 |
| 28 | NME2 | 1.51863849 |
| 29 | MYLK | 1.49598241 |
| 30 | JAK1 | 1.48221781 |
| 31 | DMPK | 1.46449398 |
| 32 | TBK1 | 1.38452155 |
| 33 | OBSCN | 1.32516872 |
| 34 | PDGFRA | 1.30506176 |
| 35 | MAP3K6 | 1.30332200 |
| 36 | ARAF | 1.28159028 |
| 37 | MST1R | 1.25413051 |
| 38 | PRKAA2 | 1.25244084 |
| 39 | FGFR3 | 1.24871610 |
| 40 | PIK3CA | 1.23095064 |
| 41 | TYK2 | 1.17229552 |
| 42 | TIE1 | 1.14922242 |
| 43 | KIT | 1.13574195 |
| 44 | CDC42BPA | 1.12046782 |
| 45 | DAPK3 | 1.03721699 |
| 46 | JAK2 | 1.01863640 |
| 47 | CDK9 | 1.01368436 |
| 48 | ABL2 | 0.98142516 |
| 49 | GRK5 | 0.97708437 |
| 50 | MAPK7 | 0.94402869 |
| 51 | MAP3K14 | 0.94351102 |
| 52 | PDPK1 | 0.92051391 |
| 53 | LIMK1 | 0.91447872 |
| 54 | GRK7 | 0.89404665 |
| 55 | JAK3 | 0.85536244 |
| 56 | FLT3 | 0.85089877 |
| 57 | KDR | 0.84689347 |
| 58 | TRPM7 | 0.80625074 |
| 59 | MAP2K3 | 0.80244427 |
| 60 | EPHB2 | 0.80165330 |
| 61 | PKN1 | 0.79883842 |
| 62 | PRKD1 | 0.77623475 |
| 63 | MAP2K1 | 0.77137927 |
| 64 | CDK6 | 0.75961177 |
| 65 | IRAK4 | 0.75602129 |
| 66 | PRPF4B | 0.74936445 |
| 67 | PDGFRB | 0.73952841 |
| 68 | MAPKAPK3 | 0.73159368 |
| 69 | PDK1 | 0.72937814 |
| 70 | PRKG1 | 0.72757084 |
| 71 | ROCK2 | 0.72016407 |
| 72 | CSK | 0.72011113 |
| 73 | FGFR4 | 0.70634082 |
| 74 | MARK1 | 0.70370299 |
| 75 | WNK4 | 0.70343515 |
| 76 | CAMKK2 | 0.69550287 |
| 77 | FRK | 0.69202311 |
| 78 | PRKAA1 | 0.68695540 |
| 79 | PINK1 | 0.68418065 |
| 80 | ROCK1 | 0.68135339 |
| 81 | PRKCH | 0.67152214 |
| 82 | BMX | 0.67078380 |
| 83 | SGK2 | 0.66665337 |
| 84 | FER | 0.66644120 |
| 85 | TYRO3 | 0.65194196 |
| 86 | PAK4 | 0.63419109 |
| 87 | CAMK2G | 0.62571258 |
| 88 | NLK | 0.62344204 |
| 89 | EEF2K | 0.61968268 |
| 90 | MAP3K5 | 0.61344195 |
| 91 | FES | 0.60785580 |
| 92 | TAOK3 | 0.60668563 |
| 93 | ILK | 0.59470610 |
| 94 | SGK3 | 0.58725014 |
| 95 | CAMK2B | 0.57568699 |
| 96 | STK4 | 0.56519454 |
| 97 | IGF1R | 0.55405517 |
| 98 | MAP3K11 | 0.55229659 |
| 99 | IRAK1 | 0.54744164 |
| 100 | ADRBK2 | 0.53480367 |
| 101 | EPHB1 | 0.53361119 |
| 102 | RPS6KL1 | 0.53234065 |
| 103 | RPS6KC1 | 0.53234065 |
| 104 | MAP3K3 | 0.52892155 |
| 105 | PRKACG | 0.51916159 |
| 106 | CAMK4 | 0.51470845 |
| 107 | KSR2 | 0.51266279 |
| 108 | MTOR | 0.49308205 |
| 109 | CSF1R | 0.48761029 |
| 110 | STK24 | 0.48214994 |
| 111 | MAP3K13 | 0.47955531 |
| 112 | MAPK12 | 0.47800919 |
| 113 | PAK2 | 0.47345106 |
| 114 | CAMK2A | 0.47179768 |
| 115 | ABL1 | 0.47045461 |
| 116 | PRKACB | 0.47012650 |
| 117 | SGK223 | 0.46559283 |
| 118 | SGK494 | 0.46559283 |
| 119 | PTK2B | 0.45480044 |
| 120 | RET | 0.44695807 |
| 121 | PTK6 | 0.44582845 |
| 122 | HCK | 0.44383799 |
| 123 | BLK | 0.43804635 |
| 124 | MAP3K1 | 0.42644423 |
| 125 | TEC | 0.42438522 |
| 126 | RPS6KA2 | 0.42315799 |
| 127 | IKBKB | 0.41639626 |
| 128 | IKBKE | 0.40215271 |
| 129 | PRKCE | 0.40058733 |
| 130 | GSK3A | 0.39404789 |
| 131 | IRAK2 | 0.37204358 |
| 132 | DAPK2 | 0.35244064 |
| 133 | EPHA3 | 0.35111902 |
| 134 | INSR | 0.35049845 |
| 135 | MAPK11 | 0.34934470 |
| 136 | MARK3 | 0.34471684 |
| 137 | ZAP70 | 0.32374883 |
| 138 | STK3 | 0.31098045 |
| 139 | NEK1 | 0.29407621 |
| 140 | PRKD3 | 0.28957050 |
| 141 | SRC | 0.28656658 |
| 142 | EGFR | 0.28646689 |
| 143 | CAMK2D | 0.28442300 |
| 144 | LATS1 | 0.27724653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.50921357 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.03044260 |
| 3 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 3.32894303 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.27490307 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.07887851 |
| 6 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.97005095 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.92787937 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.89160056 |
| 9 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.82295182 |
| 10 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.05937572 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.91190895 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 1.90045893 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.59474556 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56575538 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.54813372 |
| 16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51611038 |
| 17 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.48449816 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47884280 |
| 19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.46800731 |
| 20 | Insulin resistance_Homo sapiens_hsa04931 | 1.41055225 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38671231 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.24782456 |
| 23 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.20783748 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17644336 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15064924 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10647439 |
| 27 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.10476878 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08612647 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06642304 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05919251 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.05473703 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01668922 |
| 33 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.00149206 |
| 34 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.98351001 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 0.97191295 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96941611 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96918101 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 0.94416370 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91616228 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 0.90889479 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90882273 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 0.88847109 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83449894 |
| 44 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81531825 |
| 45 | Malaria_Homo sapiens_hsa05144 | 0.81281689 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.79971472 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77455940 |
| 48 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77326014 |
| 49 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77321059 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73963710 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 0.73421913 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 0.73403085 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72426146 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 0.72004804 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.71026636 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71023022 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68474102 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68437494 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67231637 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66843073 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66639124 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66565580 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66409091 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.66280237 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65954104 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65513385 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62225214 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.61124356 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60058933 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56258042 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.56122700 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55294265 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51682820 |
| 74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50006635 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48004548 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46737861 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46384315 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46299691 |
| 79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.45893197 |
| 80 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45739574 |
| 81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.45631441 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45469356 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44861554 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.44622383 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43841343 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43335383 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.43284503 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43078819 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41933995 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41918971 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.40662270 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40637020 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.39704266 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39050087 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.38582151 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37479291 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37430253 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37199683 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35584887 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35452460 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35194685 |
| 102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34798075 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.34132407 |
| 104 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.33947149 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.33829281 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.33718678 |
| 107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.33336840 |
| 108 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33225327 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32803730 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32774324 |
| 111 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.32698937 |
| 112 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.31927614 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.31812771 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31298256 |
| 115 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.31254413 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30968909 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30775354 |
| 118 | Melanoma_Homo sapiens_hsa05218 | 0.30669141 |
| 119 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30586225 |
| 120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.30123684 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.30019451 |
| 122 | Adherens junction_Homo sapiens_hsa04520 | 0.29779570 |
| 123 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.29612386 |
| 124 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28909927 |
| 125 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28587174 |
| 126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28444563 |
| 127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.27860554 |
| 128 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.27659849 |
| 129 | Measles_Homo sapiens_hsa05162 | 0.27021144 |
| 130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26918561 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26918383 |
| 132 | Influenza A_Homo sapiens_hsa05164 | 0.26312432 |
| 133 | Apoptosis_Homo sapiens_hsa04210 | 0.24834751 |
| 134 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23990996 |
| 135 | Hepatitis C_Homo sapiens_hsa05160 | 0.23305712 |
| 136 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.23140402 |
| 137 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.22824883 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22749336 |

